ENVB
Enveric Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.41
+2.17%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.76
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +86.4%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | — | -$0.76 | — | — |
| May 15, 2026 | — | -$1.08 | — | — |
| Mar 27, 2026 | -$56 | $0.85 | Beat 101.52% | — |
| Nov 14, 2025 | -$63 | -$11 | Beat 82.84% | — |
| Aug 14, 2025 | -$63 | -$12 | Beat 81.52% | — |
| May 14, 2025 | -$6.00 | -$1.22 | Beat 79.67% | — |
| Mar 31, 2025 | -$3.45 | -$22 | Miss -534.49% | $340.4K |
| Nov 14, 2024 | -$7.80 | -$3.60 | Beat 53.85% | — |
| Nov 13, 2023 | -$29 | -$19 | Beat 32.65% | — |
| Aug 14, 2023 | -$0.65 | -$46 | Miss -6912.31% | — |
| Jun 8, 2023 | — | -$6.76 | — | — |
| Nov 14, 2022 | -$4.00 | -$22 | Miss -447.25% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026